| - GRCh37:
- Chr16:11001864
- GRCh38:
- Chr16:10908007
| CIITA | R791G, R839G, R790G, R840G, R816G | Rheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
| Uncertain significance (Sep 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:10996517
- GRCh38:
- Chr16:10902660
| CIITA | P162S, P163S, P211S, P188S, P212S | Rheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
| Uncertain significance (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:11001724
- GRCh38:
- Chr16:10907867
| CIITA | Y743F, Y744F, Y769F, Y792F, Y793F | MHC class II deficiency, Rheumatoid arthritis | Uncertain significance (Mar 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:10998628
- GRCh38:
- Chr16:10904771
| CIITA | P273L, P274L, P299L, P322L, P323L | MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
| Uncertain significance (Mar 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:10989260
- GRCh38:
- Chr16:10895403
| CIITA | | MHC class II deficiency, Rheumatoid arthritis | Uncertain significance (Sep 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:11004059
- GRCh38:
- Chr16:10910202
| CIITA | S360L, S895L, S896L, S921L, S944L, S945L | MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
| Uncertain significance (Jan 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:11001913
- GRCh38:
- Chr16:10908056
| CIITA | A806V, A807V, A832V, A855V, A856V | MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
| Uncertain significance (Feb 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:38799129
- GRCh38:
- Chr4:38797508
| TLR1 | C442R | Rheumatoid arthritis | Pathogenic (Nov 2, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr4:38798417
- GRCh38:
- Chr4:38796796
| TLR1 | I679T | Rheumatoid arthritis | Pathogenic (Nov 2, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:233408368
- GRCh38:
- Chr2:232543658
| CHRNG | R332W | not specified, Autosomal recessive multiple pterygium syndrome | Conflicting interpretations of pathogenicity (Jun 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:17660499
- GRCh38:
- Chr1:17334004
| PADI4 | G112A | Rheumatoid arthritis, Abnormal pulmonary interstitial morphology | association (Feb 1, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr1:17662662
- GRCh38:
- Chr1:17336167
| PADI4 | | Rheumatoid arthritis, Abnormal pulmonary interstitial morphology | association (Feb 1, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr1:17657616
- GRCh38:
- Chr1:17331121
| PADI4 | V82A | Rheumatoid arthritis, Abnormal pulmonary interstitial morphology | association (Feb 1, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr1:17657534
- GRCh38:
- Chr1:17331039
| PADI4 | G55S | Rheumatoid arthritis, Abnormal pulmonary interstitial morphology | association (Feb 1, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr1:17444769
- GRCh38:
- Chr1:17118274
| PADI2 | | Rheumatoid arthritis, Abnormal pulmonary interstitial morphology | association (Feb 1, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr1:17413121
- GRCh38:
- Chr1:17086626
| PADI2 | | Rheumatoid arthritis, Abnormal pulmonary interstitial morphology | association (Feb 1, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr1:17405949
- GRCh38:
- Chr1:17079454
| PADI2 | | Rheumatoid arthritis, Abnormal pulmonary interstitial morphology | association (Feb 1, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr1:17395281
- GRCh38:
- Chr1:17068786
| PADI2 | | Rheumatoid arthritis, Abnormal pulmonary interstitial morphology | association (Feb 1, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr16:11001288
- GRCh38:
- Chr16:10907431
| CIITA | R624C, R598C, R647C, R648C, R599C | MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
| Uncertain significance (Jul 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:11016071
- GRCh38:
- Chr16:10922214
| CIITA | R1017H, R1018H, R1043H, R1066H, R1067H, R482H | Inborn genetic diseases, MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency | Conflicting interpretations of pathogenicity (Aug 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:11001462
- GRCh38:
- Chr16:10907605
| CIITA | E656K, E657K, E705K, E682K, E706K | MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
| Uncertain significance (Mar 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:11001462
- GRCh38:
- Chr16:10907605
| CIITA | E657Q, E682Q, E706Q, E656Q, E705Q | Rheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
| Uncertain significance (Sep 28, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:10992600
- GRCh38:
- Chr16:10898743
| CIITA | | MHC class II deficiency, MHC class II deficiency, Rheumatoid arthritis
| Benign (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:11004037
- GRCh38:
- Chr16:10910180
| CIITA | | MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
| Conflicting interpretations of pathogenicity (Mar 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:11347858
- GRCh38:
- Chr16:11254001
| SOCS1, SOCS1, SOCS1 | | Rheumatoid arthritis | Affects (Nov 30, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr16:10997746
- GRCh38:
- Chr16:10903889
| CIITA | M311V, M262V, M312V, M263V, M288V | MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
| Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:10997744
- GRCh38:
- Chr16:10903887
| CIITA | N310I, N311I, N261I, N262I, N287I | MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
| Uncertain significance (Mar 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:11017111
- GRCh38:
- Chr16:10923254
| CIITA | S1115N, S1116N, S531N, S1066N, S1067N, S1092N | Rheumatoid arthritis, MHC class II deficiency, MHC class II deficiency, Rheumatoid arthritis, Colitis, Thrombocytopenia, Inflammation of the large intestine, Hematochezia | Uncertain significance (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:17484166
- GRCh38:
- Chr1:17157671
| PADI4 | | Rheumatoid arthritis | association | no assertion criteria provided |
| - GRCh37:
- Chr1:17662639
- GRCh38:
- Chr1:17336144
| PADI4 | | Rheumatoid arthritis | association | no assertion criteria provided |
| - GRCh37:
- Chr16:11000905
- GRCh38:
- Chr16:10907048
| CIITA | P519L, P520L, P470L, P471L, P496L | MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
| Uncertain significance (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:10992538
- GRCh38:
- Chr16:10898681
| CIITA | Q103K, Q79K | MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
| Uncertain significance (Dec 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:11016091
- GRCh38:
- Chr16:10922234
| CIITA | S1073T, S1074T, S489T, S1025T, S1050T, S1024T | MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
| Uncertain significance (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:10992836
- GRCh38:
- Chr16:10898979
| CIITA | V138A, V139A, V115A | MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
| Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:37622040
- GRCh38:
- Chr13:37047903
| SUPT20H | K25* | Rheumatoid arthritis | risk factor (Jun 16, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr16:10989612
- GRCh38:
- Chr16:10895755
| CIITA | A96T, A72T | Inborn genetic diseases, MHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency | Uncertain significance (Aug 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:10989256
- GRCh38:
- Chr16:10895399
| CIITA | A57D, A33D | MHC class II deficiency, Rheumatoid arthritis | Conflicting interpretations of pathogenicity (May 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:206945738
- GRCh38:
- Chr1:206772393
| IL10, IL19, LOC128462409 | G15R | Inflammatory bowel disease, not provided, Susceptibility to HIV infection, Graft-versus-host disease, susceptibility to, Rheumatoid arthritis | Conflicting interpretations of pathogenicity (Oct 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:11018177
- GRCh38:
- Chr16:10924320
| CIITA | | Rheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
| Uncertain significance (Aug 4, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:11017837
- GRCh38:
- Chr16:10923980
| CIITA | | Rheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
| Uncertain significance (Oct 4, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:11002000
- GRCh38:
- Chr16:10908143
| CIITA | R884H, R885H, R835H, R836H, R861H | Rheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
| Uncertain significance (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:11001445
- GRCh38:
- Chr16:10907588
| CIITA | P699L, P700L, P650L, P651L, P676L | Rheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
| Uncertain significance (Mar 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:10970902
- GRCh38:
- Chr16:10877045
| CIITA | | Rheumatoid arthritis | risk factor (Oct 1, 2006) | no assertion criteria provided |
| - GRCh37:
- Chr1:114377568
- GRCh38:
- Chr1:113834946
| AP4B1-AS1, PTPN22 | R620W, R596W, R565W | not provided | Benign (Oct 17, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31515340
- GRCh38:
- Chr6:31547563
| NFKBIL1 | | Rheumatoid arthritis | risk factor (Feb 1, 2003) | no assertion criteria provided |
| - GRCh37:
- Chr5:131637309
- GRCh38:
- Chr5:132301616
| SLC22A4 | | Rheumatoid arthritis | risk factor (Dec 1, 2003) | no assertion criteria provided |
| - GRCh37:
- Chr1:160807715
- GRCh38:
- Chr1:160837925
| CD244 | | Rheumatoid arthritis | risk factor (Oct 1, 2008) | no assertion criteria provided |
| - GRCh37:
- Chr7:128578301
- GRCh38:
- Chr7:128938247
| IRF5 | | Rheumatoid arthritis, Systemic lupus erythematosus, susceptibility to, 10 | Pathogenic; risk factor (Mar 15, 2008) | no assertion criteria provided |